Trial Details
COMPLETEDBasic Information
| Clinical ID | c3263 |
|---|---|
| Identifier | NCT02316899 |
| Trial Title | Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation (IBS-C) |
| Interventions | DRUG: linaclotide|DRUG: Placebo |
Participant Information
| Sponsor | Astellas Pharma Inc |
|---|---|
| City | Aichi |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-10-21 |
|---|---|
| Primary Completion Date | 2015-09-19 |
| Completion Date | 2016-03-29 |